[
    [
        {
            "time": "",
            "original_text": "【万联医药】雄关漫道真如铁，而今迈步从头越——迈瑞医疗（300760）深度报告（下）",
            "features": {
                "keywords": [
                    "万联医药",
                    "迈瑞医疗",
                    "深度报告"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【万联医药】雄关漫道真如铁，而今迈步从头越——迈瑞医疗（300760）深度报告（下）",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "康基医疗IPO诊断报告：“两票制”冲击销售模式，研发费用率远逊同行",
            "features": {
                "keywords": [
                    "康基医疗",
                    "IPO",
                    "两票制",
                    "销售模式",
                    "研发费用率"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康基医疗IPO诊断报告：“两票制”冲击销售模式，研发费用率远逊同行",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]